אינג'י 10 מג80 מג טבליות

Negara: Israel

Bahasa: Ibrani

Sumber: Ministry of Health

Bahan aktif:

EZETIMIBE; SIMVASTATIN

Tersedia dari:

MERCK SHARP & DOHME ISRAEL LTD

Kode ATC:

C10AA01

Bentuk farmasi:

טבליה

Komposisi:

SIMVASTATIN 80 MG; EZETIMIBE 10 MG

Rute administrasi :

פומי

Jenis Resep:

מרשם נדרש

Diproduksi oleh:

MERCK SHARP & DOHME B.V., THE NETHERLANDS

Kelompok Terapi:

SIMVASTATIN

Area terapi:

SIMVASTATIN

Indikasi Terapi:

Hypercholesterolemia: Inegy is indicated as adjunctive therapy to diet for use in patients with primary ( heterozygous familial and nonfamilial) hypercholesterolemia or mixed hyperlipidemia where use of a combination product is appropriate: - patients not appropriately controlled with a statin alone - patients already treated with a statin and ezetimibe. Inegy contains ezetimibe and simvastatin. Simvastatin ( 20 - 40 mg ) has been shown to reduce the frequency of cardiovascular events. Studies to demonstrate the efficacy of inegy or ezetimibe in the prevention of complications of atherosclerosis have not been completed. Homozygous familial hypercholesterolemia (HoFH): Inegy is indicated as adjunctive therapy to diet for use in patients with HoFH. Patients may also receive adjunctive treatments ( e.g. low-density lipoprotein [LDL] apheresis).

Tanggal Otorisasi:

2012-04-30